New Products

New Products

Our extensive selection of Cytokine, Antibody, ELISA, and Media products is continuously expanding to address your current research interests.

Here you can find a list of our newly released products.

New
Size
95.00 USD 10µg
215.00 USD 50µg
330.00 USD 100µg
577.50 USD 250µg
990.00 USD 500µg
1,650.00 USD 1mg
Looking for a custom size?
Contact Us

Animal-Free Recombinant Human BMP-13/CDMP-2

BMP-13 is expressed in hypertrophic chondrocytes during embryonic development of long bones. Continued postnatal expression of BMP-13 in articular cartilage suggests that it plays a regulatory role in the growth and maintenance of articular cartilage. Adenovirus-mediated BMP-13 gene transfer to rabbit bone marrow stem cells have been reported to augment periosteal repair of osteochondral defects. The functional form of BMP-13/CDMP-2 is a disulfide-linked homodimer of two 120 amino-acid polypeptide chains. This 27.5 kDa protein is obtained by proteolytic processing of a biologically inactive precursor protein of 97.7kDa. Recombinant Human BMP-13/CDMP-2 is a 27.0 kDa homodimeric disulfide-linked protein consisting of two 120 amino acid polypeptide chains. 

Manufactured using all Animal-Free reagents.

Source: E.coli

Synonyms: Bone Morphogenetic Protein-13, GDF-6, Cartilage-Derived Morphogenetic Protein-2 (CDMP-2)

AA Sequence (monomer): TAFASRHGKR HGKKSRLRCS KKPLHVNFKE LGWDDWIIAP LEYEAYHCEG VCDFPLRSHL EPTNHAIIQT LMNSMDPGST PPSCCVPTKL TPISILYIDA GNNVVYKQYE DMVVESCGCR

Purity: Greater than 95% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 2.0-3.0 µg/ml.

New
Size
95.00 USD 5µg
215.00 USD 20µg
396.00 USD 50µg
660.00 USD 100µg
1,155.00 USD 250µg
1,980.00 USD 500µg
3,300.00 USD 1mg
Looking for a custom size?
Contact Us

Animal-Free Recombinant Human I-TAC (CXCL11)

I-TAC is a 'non-ELR' CXC chemokine that is regulated by interferon and signals through the CXCR3 receptor. I-TAC is chemoattractant for IL-2 activated T cells, but does not affect freshly isolated un-stimulated T cells, neutrophils, ormonocytes. Recombinant Human I-TAC (CXCL11) is an 8.3 kDa protein containing 73 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines. 

Manufactured using all Animal-Free reagents.

Source: E.coli

Synonyms: Interferon Inducible T-Cell α Chemokine, B-R1

AA Sequence: FPMFKRGRCL CIGPGVKAVK VADIEKASIM YPSNNCDKIE VIITLKENKG QRCLNPKSKQ ARLIIKKVER KNF

Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to chemoattract human T-cells activated with IL-2.

New
Size
95.00 USD 5µg
215.00 USD 20µg
660.00 USD 100µg
1,155.00 USD 250µg
1,980.00 USD 500µg
3,300.00 USD 1mg
Looking for a custom size?
Contact Us

Animal-Free Recombinant Human sTNF Receptor Type I

TNFRI belongs to the TNFR superfamily of transmembrane proteins, and is expressed in most cell types. Binding of either TNF-α or TNF-β to TNFRI initiates a signal transduction pathway that results in the activation of the transduction factor NF-κB, whose target genes are involved in the regulation of inflammatory responses, and, in certain cells induce apoptosis. Soluble TNF Receptor I (sTNFRI) is capable of inhibiting TNF-α and TNF-β activities by acting as a decoy receptor that serves as a sink for the TNF ligands. The human TNFRI gene encodes for a 455 amino acid type I transmembrane protein, which contains a 21 amino acid signal sequence, a 190 amino acid extracellular domain, a 23 amino acid transmembrane domain, and a 221 amino acid cytoplasmic domain. Recombinant Human sTNF Receptor Type I is an 18.3 kDa protein (162 amino acid residues) comprising the cysteine-rich, ligand-binding portion of the extracellular domain of the TNFRI protein.

Manufactured using all Animal-Free reagents.

Source: E.coli

Synonyms: soluble Tumor Necrosis Factor Type I, TNFRSF1A, TNFAR, p60, p55, CD120a, TNFR1

AA Sequence: MDSVCPQGKY IHPQNNSICC TKCHKGTYLY NDCPGPGQDT DCRECESGSF TASENHLRHC LSCSKCRKEM GQVEISSCTV DRDTVCGCRK NQYRHYWSEN LFQCFNCSLC LNGTVHLSCQ EKQNTVCTCH AGFFLRENEC VSCSNCKKSL ECTKLCLPQI EN

Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its inhibitory effect of the TNF-α mediated cytotoxicity in murine L-929 cells. The  ED50  for this effect in the presence of 0.25 ng/ml of Recombinant Human TNF-α, is 0.05 µg/ml.

New
Size
95.00 USD 2µg
215.00 USD 10µg
1,140.00 USD 100µg
1,995.00 USD 250µg
3,420.00 USD 500µg
5,700.00 USD 1mg
Looking for a custom size?
Contact Us

Animal-Free Recombinant Murine IL-21

IL-21 is a pleiotropic cytokine produced by CD4+ T cells in response to antigenic stimulation. Its action generally enhances antigen-specific responses of immune cells. The biological effects of IL-21 include: inducing the differentiation of T-cell-stimulated B-cells into plasma cells and memory B-cells; the stimulation of IgG production in conjunction with IL-4; and the induction of apoptotic effects in naïve B-cells and stimulated B-cells in the absence of T-cell signaling. Additionally, IL-21 promotes the anti-tumor activity of CD8+ T-cells and NK cells. IL-21 exerts its effect through binding to a specific type I cytokine receptor, IL-21R, which also contains the γ chain (γc) found in other cytokine receptors, including IL-2, IL-4, IL-7, IL-9 and IL-15. The IL-21/IL-21R interaction triggers a cascade of events, which includes activation of the tyrosine kinases JAK1 and JAK3, followed by activation of the transcription factors STAT1 and STAT3. Recombinant Murine IL-21 is a 15.0 kDa protein consisting of 130 amino acid residues.

Manufactured using all Animal-Free reagents.

Source: E.coli

Synonyms: Interleukin-21, Za11

AA Sequence: MHKSSPQGPD RLLIRLRHLI DIVEQLKIYE NDLDPELLSA PQDVKGHCEH AAFACFQKAK LKPSNPGNNK TFIIDLVAQL RRRLPARRGG KKQKHIAKCP SCDSYEKRTP KEFLERLKWL LQKMIHQHLS

Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to stimulate the proliferation of human ANBL-6 cells. The expected ED50 is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 106 units/mg.

New
Size
275.00 USD 500mL
Looking for a custom size?
Contact Us

PeproGrow™ hMSC Mesenchymal Stem Cell Media

PeproGrow hMSC (Mesenchymal Stem Cell) Medium is a xeno-free, human serum containing, phenol red-free complete media formulation originally designed for thein vitro expansion of adipose-derived human mesenchymal stem cells (ADMSCs) while maintaining full multipotency. Since its design, this media formulation has been shown to be suitable for the sustained growth of adipose tissue-derived, bone marrow-derived, umbilical cord-derived, placental-derived, and urine-derived MSCs in both adherent and suspension culture. For optimal results, culturing should be conducted on a surface coated with PeproTech’s Animal-Free Human Vitronectin Matrix as a surface-coating reagent; however, other suitable extracellular matrix (ECM) proteins, such as fibronectin or vitronectin, can be used. PeproGrow hMSC Medium was designed and developed in collaboration with American CryoStem Corporation, and is supplied as a 500mL bottle of PeproGrow hMSC Basal Medium containing a human serum component, and a separate, lyophilized vial of animal-free PeproGrow hMSC Growth Factor Supplement. The addition of the separate, lyophilized growth factor supplement to the basal medium results in a complete medium containing all growth factors and supplements necessary for optimal expansion of human mesenchymal stem cells in culture. Additional companion products, including PeproTech’s Animal-Free Vitronectin Matrix and Buffer Kit, are available separately.

MSC growth curve

 

New
Size
80.00 USD 2µg
195.00 USD 10µg
1,040.00 USD 100µg
1,820.00 USD 250µg
3,120.00 USD 500µg
5,200.00 USD 1mg
Looking for a custom size?
Contact Us

Recombinant Human IL-36α (IL-1F6)

The IL-1 family is comprised of 11 structurally related ligands, including recently re-named IL-36α (IL-1F6), β (IL-1F8), and γ (IL-1F9). IL-36α is highly expressed in psoriatic plaques, as are IL-36β and IL-36γ, and is the only IL-1 family member found to be expressed by T-cells, as well as monocytes and B-cells. Primarily found in skin and lymphoid tissues, IL-36α is also found to a lesser extent in tissues of the fetal brain, trachea, stomach, and intestine. IL-36α signals through a combination of the IL-1Rrp2 (IL-1R6) receptor, which is primarily expressed on certain dendritic cells, and the widely expressed IL-RAcP (IL-1 receptor accessory protein). IL-36α also functions as an agonist of NF-kappaB and MAPK pathways, and induces the production of proinflammatory cytokines and chemokines, including IL-6, IL-8, BD-2, and BD-3. Recombinant human IL-36α is a 17.2 kDa protein containing 154 amino acid residues.

Source: E.coli

Synonyms: Interleukin-36α, IL36A, Interleukin-1 family member 6 (IL-1F6), FIL1ε (FIL1E), Interleukin-1ε (IL1E)

AA Sequence: MKIDTPQQGS IQDINHRVWV LQDQTLIAVP RKDRMSPVTI ALISCRHVET LEKDRGNPIY LGLNGLNLCL MCAKVGDQPT LQLKEKDIMD LYNQPEPVKS FLFYHSQSGR NSTFESVAFP GWFIAVSSEG GCPLILTQEL GKANTTDFGL TMLF

Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Measured by its ability to inhibit secretion of IL-8 by A431 cells in the prescence of IL-36γ.

New
Size
80.00 USD 10µg
195.00 USD 50µg
300.00 USD 100µg
525.00 USD 250µg
900.00 USD 500µg
1,500.00 USD 1mg
Looking for a custom size?
Contact Us

Recombinant Human TLR-4

Characterized by N-terminal domains rich in leucine repeats and C-terminal intracellular Toll/interleukin (IL)-1 (TIL) domains, the structurally-related members of the Toll-like Receptor (TLR) family are abundantly expressed, transmembrane signaling receptors that play integral roles in the induction of innate and adaptive immunity. As members of the larger family of pattern recognition receptors, TLRs recognize and respond to pathogen-associated molecular patterns (PAMPs) and endogenous damage-associated molecular patterns (DAMPs) by initiating activation of NF-κB and the release of inflammatory mediators. Constitutively expressed in cells of the immune system, TLR-4 is secreted at significantly amplified levels in response to high concentrations of LPS, the major cell wall component of gram-negative bacteria that acts as the key ligand for TLR-4 inflammatory response. TLR-4 mounts a defense against infection through an intricate process involving interaction with co-stimulatory molecules, such as myeloid differentiation factor 88 (MyD88), NF-κB, LPS-Binding Protein (LBP), CD14, and MD-2, and the instigation of intracellular signaling cascade that prompts the NF-κB, Wnt/β-catenin, and mitogen-activated protein kinase (MAPK) pathways to secrete proinflammatory cytokines and chemokines. Myeloid differentiation protein-2 (MD-2), also referred to as LY96, is essential to TLR-4-mediated response to LPS due to its binding of both the extracellular domain of TLR-4, which serves to localize TLR-4 on the cell surface, and LPS to form the TLR-4/MD-2/LPS complex, which can be used for the in vitro removal of endotoxin from biological samples. The activation of TLR-4/MD-2 begins with the detection of LPS by circulating LBP, which in turn facilitates an association between LPS and CD14 for the formation of a CD14-LPS complex that transports and presents LPS to the TLR-4/MD-2 signaling complex, and culminates in the activation of downstream signaling events. Inflammatory response can also be triggered by the formation of a heterodimeric complex between TLR-6 and TLR-4, the internalization of which results in NF-κB-dependent secretion of CXCL1, as well as the production of proinflammatory cytokines, such as IL-1β, and the production of inflammatory regulating chemokines, such as CXCL2, CCL5 and CCL9. Considering TLR-4’s connections to immunity, inflammatory response, proliferation, apoptosis and angiogenesis, it is no surprise that irregular expression of TLR-4 has been linked to various malignant cell types, a number of autoimmune conditions genetically linked to psoriasis, and a number of other diseases. Recombinant Human TLR-4 is a 69.3 kDa glycoprotein containing 609 amino acid residues of the TLR-4 extracellular domain. As a result of glycosylation, Recombinant Human TLR-4 migrates with an apparent molecular mass of approximately 90-100 kDa by SDS-PAGE gel, under reducing and non-reducing conditions.

Source: HEK293 cells

Synonyms: Toll-like receptor 4, TOLL, CD284, ARMD10

AA Sequence: ESWEPCVEVV PNITYQCMEL NFYKIPDNLP FSTKNLDLSF NPLRHLGSYS FFSFPELQVL DLSRCEIQTI EDGAYQSLSH LSTLILTGNP IQSLALGAFS GLSSLQKLVA VETNLASLEN FPIGHLKTLK ELNVAHNLIQ SFKLPEYFSN LTNLEHLDLS SNKIQSIYCT DLRVLHQMPL LNLSLDLSLN PMNFIQPGAF KEIRLHKLTL RNNFDSLNVM KTCIQGLAGL EVHRLVLGEF RNEGNLEKFD KSALEGLCNL TIEEFRLAYL DYYLDDIIDL FNCLTNVSSF SLVSVTIERV KDFSYNFGWQ HLELVNCKFG QFPTLKLKSL KRLTFTSNKG GNAFSEVDLP SLEFLDLSRN GLSFKGCCSQ SDFGTTSLKY LDLSFNGVIT MSSNFLGLEQ LEHLDFQHSN LKQMSEFSVF LSLRNLIYLD ISHTHTRVAF NGIFNGLSSL EVLKMAGNSF QENFLPDIFT ELRNLTFLDL SQCQLEQLSP TAFNSLSSLQ VLNMSHNNFF SLDTFPYKCL NSLQVLDYSL NHIMTSKKQE LQHFPSSLAF LNLTQNDFAC TCEHQSFLQW IKDQRQLLVE VERMECATPS DKQGMPVLSL NITCQMNKT

Purity: Greater than 95% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to bind rhMD-2 in a functional ELISA.

New
Size
80.00 USD 5µg
195.00 USD 25µg
600.00 USD 100µg
1,050.00 USD 250µg
1,800.00 USD 500µg
3,000.00 USD 1mg
Looking for a custom size?
Contact Us

Recombinant Murine IL-36RA

The IL-1 family is comprised of 11 structurally related ligands, including the recently re-named IL-36RA (IL-1F5), IL-36α (IL-1F6), IL-36β (IL-1F8), and IL-36γ (IL-1F9). The interaction of IL-36 ligands with the IL-1Rrp2 receptor (IL-1R6) can induce various activities, including dendritic cell maturation and activation. IL-36RA can antagonize the NF-κB signaling induced by either IL-36α, β or γ by binding to the IL-1Rrp2 receptor in a manner that prevents the initiation of functional signaling. Recombinant Murine IL-36RA is an E.coli-derived 16.9 kDa protein containing 154 amino acid residues.

Source: E.coli

Synonyms: Interleukin-36RA, FIL1 delta, IL-1F5, IL-1HY1, IL-1L1, IL-1RP3, IL-1ra Homolog 1, IL-1 delta

AA Sequence: VLSGALCFRM KDSALKVLYL HNNQLLAGGL HAEKVIKGEE ISVVPNRALD ASLSPVILGV QGGSQCLSCG TEKGPILKLE PVNIMELYLG AKESKSFTFY RRDMGLTSSF ESAAYPGWFL CTSPEADQPV RLTQIPEDPA WDAPITDFYF QQCD

Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Measured by its ability to inhibit secretion of IL-8 by A431 cells in the presence of human IL-36γ.

New
Size
80.00 USD 5µg
195.00 USD 20µg
780.00 USD 100µg
1,365.00 USD 250µg
2,340.00 USD 500µg
3,900.00 USD 1mg
Looking for a custom size?
Contact Us

Recombinant Human Sclerostin

Sclerostin, a glycoprotein predominantly secreted by osteocytes, is a member of the Cerberus/DAN family of putative BMP antagonists that functions as an endogenous regulator of the canonical Wnt signaling pathway and an inhibitory regulator of bone homeostasis. Although expressed nearly exclusively by osteocytes, sclerostin can also be found at significant levels elsewhere, such as bone, bone marrow, cartilage, the kidney, and the liver, and has also been shown to be produced by hypertrophic chondrocytes and cementocytes. Like DKK family members DKK-1 and DKK-4, sclerostin plays an important regulatory role in the Wnt/β-catenin signaling pathway by forming inhibitory complexes with LDL Receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. Sclerostin has also been shown to interact directly with LRP4 via its extracellular domain to facilitate inhibition of Wnt signaling, and can catabolically promote osteoclast activity by increasing osteocyte expression of RANKL. Sclerostin’s critical involvement in the regulation of bone formation and resorption is emphasized by two bone dysplasia disorders, sclerosteosis and van Buchem disease (VBD), caused by rare autosomal recessive mutations that result in progressive bone overgrowth and hypermineralization due to markedly decreased sclerostin levels. PeproTech's CHO cell-derived Recombinant Human Sclerostin is a 186-amino-acid-length glycoprotein with a calculated molecular weight of 21.0 kDa. As a result of glycosylation, Recombinant Human Sclerostin migrates with an apparent molecular mass of approximately 26-32 kDa by SDS-PAGE gel, under non-reducing conditions.

Source: CHO cells

Synonyms: SOST, SOST1, CDD, VBCH, DAND6

AA Sequence: AFKNDATEII PELGEYPEPP PELENNKTMN RAENGGRPPH HPFETKDVSE YSCRELHFTR YVTDGPCRSA KPVTELVCSG QCGPARLLPN AIGRGKWWRP SGPDFRCIPD RYRAQRVQLL CPGGEAPRAR KVRLVASCKC KRLTRFHNQS ELKDFGTEAA RPQKGRKPRP RARSAKANQA ELENAY

Purity: Greater than 95% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to downregulate alkaline phosphatase activity in differentiating MC3T3‑E1 cells in the presence of 20ng/ml murine Wnt‑3a.

New
Size
195.00 USD 50µg
250.00 USD 100µg
1,700.00 USD 1mg
Looking for a custom size?
Contact Us

Anti-Human Amphiregulin

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human Amphiregulin. Anti-Human Amphiregulin-specific antibody was purified by affinity chromatography employing an immobilized Human Amphiregulin matrix.

Immunogen: E.coli derived Recombinant Human Amphiregulin (PeproTech catalog# 100-55B)

Sandwich ELISA: To detect Human Amphiregulin by sandwich ELISA (using 100μl/well), a concentration of 0.5-2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human Amphiregulin (500-P322Bt) as a detection antibody, allows the detection of at least 2000-4000 pg/ml of Recombinant Human Amphiregulin.

Anti-Human Amphiregulin Sandwich ELISA

Western Blot: To detect Human Amphiregulin by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible secondary reagents, the detection limit for Recombinant Human Amphiregulin is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human Amphiregulin Western Blot Unreduced Anti-Human Amphiregulin Western Blot Reduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

New
Size
195.00 USD 25µg
250.00 USD 50µg
3,400.00 USD 1mg
Looking for a custom size?
Contact Us

Biotinylated Anti-Human Amphiregulin

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human Amphiregulin. Anti-Human Amphiregulin-specific antibody was purified by affinity chromatography and then biotinylated.

Immunogen: E.coli derived Recombinant Human Amphiregulin (PeproTech catalog# 100-55B)

Sandwich ELISA: To detect Human Amphiregulin by sandwich ELISA (using 100μl/well), a concentration of 0.25-1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human Amphiregulin (500-P322) as a capture antibody, allows the detection of at least 2000-4000 pg/ml ofRecombinant Human Amphiregulin.

Biotinylated Anti-Human Amphiregulin Sandwich ELISA

Western Blot: To detect Human Amphiregulin by Western Blot analysis, this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible development reagents, the detection limit for Recombinant Human Amphiregulin is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Biotinylated Anti-Human Amphiregulin Western Blot Unreduced Biotinylated Anti-Human Amphiregulin Western Blot Reduced

Note:

1mg will be provided as 2x500μg.

New
Catalog Number: 500-P320
Size
195.00 USD 50µg
250.00 USD 100µg
1,700.00 USD 1mg
Looking for a custom size?
Contact Us

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human sCD14. Anti-Human sCD14-specific antibody was purified by affinity chromatography employing an immobilized Human sCD14 matrix.

Immunogen: HEK293 cells derived Recombinant Human sCD14 (PeproTech catalog# 110-01)

Sandwich ELISA: To detect Human sCD14 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human sCD14 (500-P320Bt) as a detection antibody, allows the detection of at least 2000-4000 pg/ml of recombinant Human sCD14.

Anti-Human sCD14 Sandwich ELISA

Western Blot: To detect Human sCD14 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for Recombinant Human sCD14 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human sCD14 Western Blot Reduced Anti-Human sCD14 Western Blot Unreduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

New
Size
195.00 USD 25µg
250.00 USD 50µg
3,400.00 USD 1mg
Looking for a custom size?
Contact Us

Biotinylated Anti-Human sCD14

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human sCD14. Anti-Human CD14-specific antibody was purified by affinity chromatography and then biotinylated.

Immunogen: HEK293 cells derived Recombinant Human sCD14 (PeproTech catalog# 110-01)

Sandwich ELISA: To detect Human sCD14 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human sCD14 (500-P320) as a capture antibody, allows the detection of at least 2000-4000 pg/ml of recombinant Human sCD14.

Biotinylated Anti-Human sCD14 Sandwich ELISA

Western Blot: To detect Human sCD14 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human sCD14 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Biotinylated Anti-Human sCD14 Western Blot Reduced Biotinylated Anti-Human sCD14 Western Blot Unreduced

Note:

1mg will be provided as 2x500μg.

New
Catalog Number: 500-P318
Size
195.00 USD 50µg
250.00 USD 100µg
1,700.00 USD 1mg
Looking for a custom size?
Contact Us

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human EPO. Anti-Human EPO-specific antibody was purified by affinity chromatography employing an immobilized Human EPO matrix.

Immunogen: CHO cells derived Recombinant Human EPO (PeproTech catalog# 100-64)

Sandwich ELISA: To detect Human EPO by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech's Biotinylated Anti-Human EPO (500-P318Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of Recombinant Human EPO.

Anti-Human EPO Sandwich ELISA

Western Blot: To detect Human EPO by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for Recombinant Human EPO is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human EPO Western Blot Unreduced Anti-Human EPO Western Blot Reduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

New
Size
195.00 USD 25µg
250.00 USD 50µg
3,400.00 USD 1mg
Looking for a custom size?
Contact Us

Biotinylated Anti-Human EPO

Source: Polyclonal Rabbit

Note:

1mg will be provided as 2x500μg.

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human EPO. Anti-Human EPO-specific antibody was purified by affinity chromatography and then biotinylated.

Immunogen: CHO cells derived Recombinant Human EPO (PeproTech catalog# 100-64)

Sandwich ELISA: To detect Human EPO by sandwich ELISA (using 100μl/well), a concentration of 0.25-1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human EPO (500-P318) as a capture antibody, allows the detection of at least 2000-4000 pg/ml of Recombinant Human EPO.

Biotinylated Anti-Human EPO Sandwich ELISA

Western Blot: To detect Human EPO by Western Blot analysis, this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible development reagents, the detection limit for Recombinant Human EPO is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Biotinylated Anti-Human EPO Western Blot Unreduced Biotinylated Anti-Human EPO Western Blot Reduced

Note:

1mg will be provided as 2x500μg.

New
Size
195.00 USD 50µg
250.00 USD 100µg
1,700.00 USD 1mg
Looking for a custom size?
Contact Us

Anti-Human sIL-2 Receptor α

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human sIL-2 Receptor α. Anti-Human sIL-2 Receptor α-specific antibody was purified by affinity chromatography and then biotinylated. Human sIL-2 Receptor α matrix.

Immunogen: CHO cells derived Recombinant Human IL-2 Receptor α (PeproTech catalog# 200-02RC)

Sandwich ELISA: To detect Human sIL-2 Receptor α by sandwich ELISA (using 100μl/well) a concentration of 0.5-2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human sIL-2 Receptor α (500-P22RBT) as a detection antibody, allows the detection of at least 2000-4000 pg/ml of Recombinant Human sIL-2 Receptor α.

Anti-Human sIL-2 Receptor α Sandwich ELISA

Western Blot: To detect Human sIL-2 Receptor α by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible secondary reagents the detection limit for Recombinant Human sIL-2 Receptor α is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human sIL-2 Receptor α Western Blot Reduced Anti-Human sIL-2 Receptor α Western Blot Unreduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

New
Size
195.00 USD 25µg
250.00 USD 50µg
3,400.00 USD 1mg
Looking for a custom size?
Contact Us

Biotinylated Anti-Human sIL-2 Receptor α

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human sIL-2 Receptor α. Anti-Human sIL-2 Receptor α-specific antibody was purified by affinity chromatography and then biotinylated. Human sIL-2 Receptor α matrix.

Immunogen: CHO cells derived Recombinant Human IL-2 Receptor α (PeproTech catalog# 200-02RC)

Sandwich ELISA: To detect Human sIL-2 Receptor α by sandwich ELISA (using 100μl/well) a concentration of 0.25-1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human sIL-2 Receptor α (500-P22RBT) as a capture antibody, allows the detection of at least 2000-4000 pg/ml of Recombinant Human sIL-2 Receptor α.

Western Blot: To detect Human sIL-2 Receptor α by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible development reagents the detection limit for Recombinant Human sIL-2 Receptor α is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

New
Catalog Number: 500-P321
Size
195.00 USD 50µg
250.00 USD 100µg
1,700.00 USD 1mg
Looking for a custom size?
Contact Us

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human PD-L1 Fc. Anti-Human PD-L1 Fc-specific antibody was purified by affinity chromatography employing an immobilized Human PD-L1 Fc matrix.

Immunogen: CHO cells derived Recombinant Human PD-L1 Fc (PeproTech catalog# 310-35)

Sandwich ELISA: To detect Human PD-L1 Fc by sandwich ELISA (using 100μl/well), a concentration of 0.5-2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Human PD-L1 Fc (500-P321BT) as a detection antibody, allows the detection of at least 2000-4000 pg/ml of Recombinant Human PD-L1 Fc.

Anti-Human PD-L1 Fc Sandwich ELISA

Western Blot: To detect Human PD-L1 Fc by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible secondary reagents, the detection limit for Recombinant Human PD-L1 Fc is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human PD-L1 Fc Western Blot Unreduced Anti-Human PD-L1 Fc Western Blot Reduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

New
Size
195.00 USD 25µg
250.00 USD 50µg
3,400.00 USD 1mg
Looking for a custom size?
Contact Us

Biotinylated Anti-Human PD-L1 Fc

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human PD-L1 Fc. Anti-Human PD-L1 Fc-specific antibody was purified by affinity chromatography and then biotinylated.

Immunogen: CHO cells derived Recombinant Human PD-L1 Fc (PeproTech catalog# 310-35)

Sandwich ELISA: To detect Human PD-L1 Fc by sandwich ELISA (using 100μl/well), a concentration of 0.25-1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human PD-L1 Fc (500-P321) as a capture antibody, allows the detection of at least 2000-4000 pg/ml of Recombinant Human PD-L1 Fc.

Biotinylated Anti-Human PD-L1 Fc Sandwich ELISA

Western Blot: To detect Human PD-L1 Fc by Western Blot analysis, this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible development reagents, the detection limit for Recombinant Human PD-L1 Fc is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Biotinylated Anti-Human PD-L1 Fc Western Blot Unreduced Biotinylated Anti-Human PD-L1 Fc Western Blot Reduced

Note:

1mg will be provided as 2x500μg.

New
Catalog Number: 500-P317
Size
195.00 USD 50µg
250.00 USD 100µg
1,700.00 USD 1mg
Looking for a custom size?
Contact Us

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits immunized with highly pure Recombinant Human TGF-β3. Anti-Human TGF-β3-specific antibody was purified by affinity chromatography employing an immobilized Human TGF-β3 matrix.

Immunogen: E.coli derived Recombinant Human TGF-β3 (PeproTech catalog# 100-36E)

Western Blot: To detect Human TGF-β3 by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 μg/ml. When used in conjunction with compatible secondary reagents, the detection limit for Recombinant Human TGF-β3 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Human TGF-β3 Western Blot Unreduced Anti-Human TGF-β3 Western Blot Reduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

showing 20 of 21